These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19549455)

  • 1. [Can application of new biological preparations alter the natural course of Crohn's disease].
    Hu PJ
    Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):91-2. PubMed ID: 19549455
    [No Abstract]   [Full Text] [Related]  

  • 2. One step ahead in the care of Crohn's disease.
    Myrelid P
    Colorectal Dis; 2015 Apr; 17(4):277-8. PubMed ID: 25800070
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologics in Crohn's disease: searching indicators for outcome.
    van der Woude CJ; Hommes DW
    Expert Opin Biol Ther; 2007 Aug; 7(8):1233-43. PubMed ID: 17696821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Dimopoulos C; Al-Bawardy B
    Inflamm Bowel Dis; 2020 Nov; 26(12):e153-e154. PubMed ID: 33043966
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on the medical treatment of Crohn's disease.
    Valentini G; Guidi L; Costanzo M; Ciarniello M; De Vitis I; Capristo E; Fedeli G
    Panminerva Med; 2003 Mar; 45(1):15-22. PubMed ID: 12682617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's Disease: Etiology, Complications, Assessment, Therapy, and Management.
    Loftus EV
    Gastroenterol Clin North Am; 2017 Sep; 46(3):xiii-xv. PubMed ID: 28838422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease].
    Peñate M; Cruz-Santamaría M; Mendoza JL; Peña AS; Díaz-Rubio M; García-Paredes J
    An Med Interna; 2003 Jan; 20(1):37-45. PubMed ID: 12666309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic inflammatory diseases. Early biologics therapy is cost effective].
    MMW Fortschr Med; 2010 May; 152(21):78-9. PubMed ID: 20608134
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment preferences of patients with Crohn's disease: Development of the IMPLICA questionnaire.
    Borruel N; Castro J; Riestra S; Costi M; Casellas F
    Rev Esp Enferm Dig; 2014 Jun; 106(6):372-80. PubMed ID: 25361447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perianal Crohn's disease.
    ten Cate Hoedemaker HO
    Neth J Med; 1994 Aug; 45(2):72-5. PubMed ID: 7936009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colonic localization of Crohn's disease. New case reports. Rectocolic Crohn's disease. Colonic Crohn's disease and sigmoid diverticulitis. Colonic Crohn's disease].
    Crosetti JP; Stoppa ; Milani
    Chirurgie; 1971; 97(4):215-9. PubMed ID: 5562841
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease].
    Auer IO; Röder A; Mittelstaedt A
    Fortschr Med; 1985 Dec; 103(46):1076-80. PubMed ID: 2935464
    [No Abstract]   [Full Text] [Related]  

  • 13. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for bowel rest in nutrition management of Crohn's disease?
    Wiese DM; Rivera R; Seidner DL
    Nutr Clin Pract; 2008; 23(3):309-17. PubMed ID: 18595864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?].
    Domènech E; López San Román A; Garcia-Planella E
    Gastroenterol Hepatol; 2010; 33(6):471-2; author reply 472-3. PubMed ID: 20435379
    [No Abstract]   [Full Text] [Related]  

  • 16. Trichuris suis therapy in Crohn's disease.
    Summers RW; Elliott DE; Urban JF; Thompson R; Weinstock JV
    Gut; 2005 Jan; 54(1):87-90. PubMed ID: 15591509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx".
    Rieder F; Hamer O; Gelbmann C; Schölmerich J; Gross V; Feuerbach S; Herfarth H; Rogler G
    Z Gastroenterol; 2006 Jul; 44(7):599-602. PubMed ID: 16823701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease.
    Aloi M; Viola F; D'Arcangelo G; Di Nardo G; Civitelli F; Casciani E; Oliva S; Nuti F; Dilillo A; Cucchiara S
    Dig Liver Dis; 2013 Jun; 45(6):464-8. PubMed ID: 23465684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease.
    Savarino E; Bodini G; Savarino V
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1245. PubMed ID: 27137733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.